Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in HIV Patients
NCT00139178Phase 4Completed
- Sponsor
- Danish HIV Research Group
- Start
- Mar 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir, ritonavir in lipoatrophy, HIV-associated lipodystrophy (HALS), hypercholesterolemia, sponsored by Danish HIV Research Group. Started Mar 2004; status: completed.
02
Drugs
lopinavirritonavir
03
Conditions
lipoatrophyHIV-associated lipodystrophy (HALS)hypercholesterolemia
Beyond the preview
Go deeper on NCT00139178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139178.